Daniela Terracciano
Overview
Explore the profile of Daniela Terracciano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
2407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miro C, Cicatiello A, Nappi A, Sagliocchi S, Acampora L, Restolfer F, et al.
Cell Metab
. 2025 Feb;
PMID: 39986272
Thyroid hormones (THs) are key modulators of energy metabolism and cross-talk with other endocrine and metabolic factors. Notably, leptin can increase hypothalamic control of TH synthesis as an adaptive metabolic...
2.
Contieri R, Claps F, Hurle R, Buffi N, Lughezzani G, Lazzeri M, et al.
Urol Oncol
. 2024 Dec;
43(3):189.e1-189.e8.
PMID: 39672689
Introduction: The nonmuscle invasive bladder cancer treated with BCG instillations in patients who smoke could potentially lead to poorer oncological results in the light of the new EAU risk groups...
3.
Veneruso I, Mennitti C, Gentile A, Di Bonito G, Ulisse J, Scarano C, et al.
Heliyon
. 2024 Dec;
10(23):e40663.
PMID: 39654779
It has been well established that the human gut microbiota plays a pivotal role in humans' health, since it is involved in nutrients' uptake, vitamins' synthesis, energy harvest, inflammatory modulation,...
4.
Ferro M, Tataru O, Fallara G, Fiori C, Manfredi M, Claps F, et al.
Minerva Urol Nephrol
. 2024 Dec;
PMID: 39625636
Background: Approximately 70% of bladder cancer is diagnosed as non-muscle invasive (NMIBC) and inflammation is known to impact the oncological outcomes. Adjuvant intravesical BCG in intermediate/high risk can lower recurrence...
5.
Mennitti C, Farina G, Imperatore A, De Fonzo G, Gentile A, La Civita E, et al.
Biomolecules
. 2024 Nov;
14(11).
PMID: 39595594
Physical activity highly impacts the neuroendocrine system and hormonal secretion. Numerous variables, both those related to the individual, including genetics, age, sex, biological rhythms, nutritional status, level of training, intake...
6.
Mennitti C, Sarno L, Calvanese M, Gentile A, Esposito G, Fulgione C, et al.
Reprod Biol
. 2024 Sep;
24(4):100947.
PMID: 39232305
The lack of reliable methods for preeclampsia (PE) early diagnosis limits the opportunities for timely prevention, diagnosis and treatment. This study aims to identify the alterations of biochemical parameters and...
7.
Ferro M, de Cobelli O, Crocetto F, Carbone G, Mirto B, Fiorenza M, et al.
Minerva Urol Nephrol
. 2024 Aug;
PMID: 39093222
Background: Black men residing in Western countries are more likely to develop prostate cancer (PCa), have higher mortality and are younger than the general population at initial diagnosis. In addition...
8.
Nicolella V, Fiorenza M, Monteiro I, Novarella F, Sirica R, DAngelo M, et al.
J Neurol Sci
. 2024 Jul;
463:123115.
PMID: 38964268
Objective: Blood neurofilament light chain (NfL) is robustly associated with disease worsening in multiple sclerosis (MS), though potentially affected by concomitant factors also determining neuro-axonal loss. We investigated the association...
9.
Ferro M, Crocetto F, La Civita E, Fiorenza M, Jannuzzi G, Carbone G, et al.
Prostate
. 2024 May;
84(12):1157-1164.
PMID: 38798011
Background: There is a strong clinical need to fill the gap of identifying clinically significant prostate cancer (csPCa) in men with prostate-specific antigen (PSA) gray zone values. Promising, but not...
10.
Monteiro I, Nicolella V, Fiorenza M, Novarella F, Carotenuto A, Lanzillo R, et al.
J Neurol
. 2024 May;
271(8):5012-5024.
PMID: 38777960
Objective: The wearing-off phenomenon is common in people with multiple sclerosis (MS) treated with ocrelizumab. We aim to evaluate the presence and severity of wearing-off to ocrelizumab in relation to...